List of life saving transplantations

FamiCord Group is the most experienced bank in Europe in preparing and releasing stem cells for transplantations. We are advancing potential stem cell uses by partnering with leading medical institutions.

Filter by:

No. Cell source Indication Area of medicine Year Type of therapy Country Age
1 cord blood neuroblastoma hematology 2007 standard therapy Poland 8
2 cord blood acute lymphoblastic leukemia hematology 2008 standard therapy Poland 5
3 cord blood cerebral ischemia neurology 2008 experimental therapy Poland 1,5
4 cord blood myelodysplastic syndrome hematology 2009 standard therapy Poland 5
5 cord blood pre -B acute lymphoblastic leukemia hematology 2010 standard therapy Hungary 1,5
6 cord blood Fanconi anemia hematology 2011 standard therapy Poland 12
7 cord blood acute myeloid leukemia hematology 2011 standard therapy Hungary 2
8 cord blood acute lymphoblastic leukemia hematology 2011 standard therapy Poland 5
9 cord blood histiocytosis hematology 2011 standard therapy Poland 2,5
10 cord blood chronic granulomatous disease hematology 2011 standard therapy Poland 7,5
11 cord blood severe aplastic anaemia hematology 2012 standard therapy Hungary 3
12 cord blood anaemia,talassemia major hematology 2012 standard therapy Turkey 6
13 cord blood talassemia major,acute lymphoblastic leukemia hematology 2012 standard therapy Turkey 3,5
14 cord blood T-acute lymphoblastic leukemia hematology 2012 standard therapy Turkey 5
15 cord blood aplastic anaemia hematology 2013 standard therapy Poland 3
16 cord blood acute myeloid leukemia hematology 2013 standard therapy Poland 3
17 cord blood beta-talassemia; agranulocytosis hematology 2013 standard therapy Turkey 8
18 cord blood X - linked lymphoproliferative syndrome hematology 2013 standard therapy Poland 10,12
19 cord blood acute lymphoblastic leukemia hematology 2014 standard therapy Turkey 7
20 cord blood acute lymphoblastic leukemia hematology 2015 standard therapy Poland 4
21 cord blood acute myeloid leukemia hematology 2016 standard therapy Jordan 6
22 cord blood autism neurology 2016 experimental therapy Poland 6
23 cord blood acute lymphoblastic leukemia hematology 2016 standard therapy Hungary 7
24 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2011 experimental therapy Poland 17,2
25 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 19,7
26 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 7,1
27 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 4,3
28 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 18,9
29 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 2,11
30 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 3,5
31 cord tissue (Wharton's jelly) acute myeloid leukemia hematology 2013 experimental therapy Poland 3,5
32 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2013 experimental therapy Poland 18,8
33 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2013 experimental therapy Poland 17,5
34 cord tissue (Wharton's jelly) neuropathy neurology 2014 experimental therapy Poland 23,6
35 cord tissue (Wharton's jelly) autism neurology 2014 experimental therapy Poland 12,6
36 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2014 experimental therapy Poland 6
37 cord tissue (Wharton's jelly) central motor coordination impairment after hypoxic ischaemia lesion at birth neurology 2014 experimental therapy Poland 2,1
38 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2014 experimental therapy Poland 60,10
39 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2014 experimental therapy Poland 24,1
40 cord tissue (Wharton's jelly) autism neurology 2014 experimental therapy Poland 8,3
41 cord tissue (Wharton's jelly) muscular dystrophy neurology 2014 experimental therapy Poland 6
42 cord tissue (Wharton's jelly) birth asphyxia; retinopathy neurology 2014 experimental therapy Poland 11,12
43 cord tissue (Wharton's jelly) cerebral palsy neurology 2014 experimental therapy Poland 4,10
44 cord tissue (Wharton's jelly) cerebral palsy neurology 2014 experimental therapy Poland 15,10
45 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 1,4
46 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 5,4
47 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2015 experimental therapy Poland 23,2
48 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,6
49 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61
50 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 56
51 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 51
52 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 65
53 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 60
54 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 52
55 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 3,8
56 cord tissue (Wharton's jelly) decerebration rigidity neurology 2015 experimental therapy Poland 9,6
57 cord tissue (Wharton's jelly) bilateral blindness ophthalmology 2015 experimental therapy Poland 36,10
58 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 11,12
59 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 7,1
60 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 15,8
61 cord tissue (Wharton's jelly) ceroid lipofuscinosis neurology 2015 experimental therapy Poland 5,1
62 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 14,5
63 cord tissue (Wharton's jelly) ceroid lipofuscinosis neurology 2015 experimental therapy Poland 7,10
64 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 3
65 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 7,1
66 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 13,1
67 cord tissue (Wharton's jelly) spina bifida neurology 2015 experimental therapy Poland 2,4
68 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 59,4
69 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 31,2
70 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 5,1
71 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 12,5
72 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 8,11
73 cord tissue (Wharton's jelly) delayed psychomotor development,deafness neurology 2015 experimental therapy Poland 3,3
74 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,5
75 cord tissue (Wharton's jelly) traumatic encephalopathy neurology 2015 experimental therapy Poland 20,11
76 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 18,8
77 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 2,7
78 cord tissue (Wharton's jelly) adrenoleukodystrophy; encephalopathy neurology 2015 experimental therapy Poland 23
79 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2015 experimental therapy Poland 11,11
80 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 40
81 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 26,1
82 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 37,1
83 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 58
84 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 35,6
85 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2015 experimental therapy Poland 11,12
86 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 44,6
87 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2015 experimental therapy Poland 15,8
88 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,6
89 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2015 experimental therapy Poland 66,2
90 cord tissue (Wharton's jelly) iatrogenic spinal cord injury neurology 2015 experimental therapy Poland 17,2
91 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2015 experimental therapy Poland 45,10
92 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 62
93 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 51,5
94 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 12,10
95 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 26,5
96 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 27
97 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 4,10
98 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 6,1
99 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 4,6
100 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 63,11
101 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 32,10
102 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 22
103 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2015 experimental therapy Poland 33,3
104 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2015 experimental therapy Poland 3,6
105 cord tissue (Wharton's jelly) spina bifida neurology 2015 experimental therapy Poland 2
106 cord tissue (Wharton's jelly) cerebellar ataxia neurology 2015 experimental therapy Poland 18,7
107 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 24,3
108 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 67,6
109 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 5,6
110 cord tissue (Wharton's jelly) polineuropathy neurology 2015 experimental therapy Poland 74,2
111 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 37,6
112 cord tissue (Wharton's jelly) stroke neurology 2015 experimental therapy Poland 62,8
113 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 58,10
114 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2015 experimental therapy Poland 30,1
115 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2015 experimental therapy Poland 10
116 cord tissue (Wharton's jelly) severe developmental delay neurology 2015 experimental therapy Poland 1,1
117 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2015 experimental therapy Poland 26,2
118 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 46,2
119 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 8,7
120 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 8,12
121 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 6,6
122 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 48,7
123 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 21,4
124 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 9,9
125 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 13,4
126 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,3
127 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 54
128 cord tissue (Wharton's jelly) intracranial injury neurology 2015 experimental therapy Poland 24,3
129 cord tissue (Wharton's jelly) stroke neurology 2015 experimental therapy Poland 54,9
130 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 24,7
131 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2015 experimental therapy Poland 65,9
132 cord tissue (Wharton's jelly) leukodystrophy neurology 2015 experimental therapy Poland 18,8
133 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 34,4
134 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 1,6
135 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 14,10
136 cord tissue (Wharton's jelly) anterior ischemic optic neuropathy ophthalmology 2015 experimental therapy Poland 54,10
137 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 16,9
138 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2015 experimental therapy Poland 34,5
139 cord tissue (Wharton's jelly) cerebellar ataxia neurology 2015 experimental therapy Poland 26,1
140 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 11,2
141 cord tissue (Wharton's jelly) adrenoleukodystrophy; encephalopathy neurology 2015 experimental therapy Poland 8,4
142 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,11
143 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 44,5
144 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,8
145 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 32,2
146 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 64
147 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 62,5
148 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 18,4
149 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 48,8
150 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,3
151 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 35,3
152 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,7
153 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12,2
154 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2016 experimental therapy Poland 3,10
155 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 14
156 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 6
157 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Łódź 65,8
158 cord tissue (Wharton's jelly) leukodystrophy neurology 2016 experimental therapy Poland 2,9
159 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59,4
160 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6
161 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,11
162 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 12,11
163 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9,7
164 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2016 experimental therapy Poland 20,3
165 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 53
166 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 33,5
167 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 22,2
168 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,3
169 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8,5
170 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 29,11
171 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 33,4
172 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 37,4
173 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 39,3
174 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 7,11
175 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 28
176 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Łódź 69,6
177 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 33,11
178 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 20,7
179 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 24,5
180 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 25,6
181 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8,5
182 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 39,10
183 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 60,10
184 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6,9
185 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 44,8
186 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 25,4
187 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 10,10
188 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 63,2
189 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54,11
190 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,9
191 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 46,9
192 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58
193 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2016 experimental therapy Poland 19,2
194 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55
195 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58,1
196 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,7
197 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 52,6
198 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59,11
199 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 28,8
200 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,9
201 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 34,9
202 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Łódź 69,3
203 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 47,9
204 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 18,8
205 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,9
206 cord tissue (Wharton's jelly) traumatic brain injury neurology 2016 experimental therapy Poland 54,9
207 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 19,5
208 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59
209 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,9
210 cord tissue (Wharton's jelly) tetraparesis orthopedics 2016 experimental therapy Poland 27,9
211 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14,9
212 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 42,7
213 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 60,5
214 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6,2
215 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 11,3
216 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9,11
217 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 49,8
218 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2016 experimental therapy Poland 69,9
219 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2016 experimental therapy Poland 69,1
220 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 13,11
221 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 45,1
222 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,4
223 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 36,1
224 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59,1
225 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,2
226 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,7
227 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,1
228 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 46,1
229 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72,4
230 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54,3
231 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,1
232 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,8
233 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 64,7
234 cord tissue (Wharton's jelly) malformation syndrome neurology 2016 experimental therapy Poland 3,5
235 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 64,2
236 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 38
237 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6,10
238 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 2,11
239 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 62,8
240 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,5
241 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 51,3
242 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2,10
243 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4,2
244 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Łódź 55,4
245 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Łódź 54,8
246 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 33,10
247 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Łódź 41,4
248 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Łódź 49,3
249 cord tissue (Wharton's jelly) choroideremia ophthalmology 2016 experimental therapy Poland 50,8
250 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 63,1
251 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 7,4
252 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,4
253 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 73,7
254 cord tissue (Wharton's jelly) leukodystrophy neurology 2016 experimental therapy Poland 2,11
255 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,6
256 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 48,3
257 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 32,7
258 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 3,11
259 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Łódź 61,11
260 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Łódź 45,8
261 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,4
262 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 79,2
263 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72,6
264 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 48,4
265 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2016 experimental therapy Poland 6,11
266 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2016 experimental therapy Poland 9,7
267 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54,2
268 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 50,9
269 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2016 experimental therapy Poland 22
270 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14,7
271 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,9
272 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 62,6
273 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 58,10
274 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12,6
275 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,2
276 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,9
277 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,4
278 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,7
279 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58,1
280 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 4,8
281 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 1,5
282 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3
283 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9,9
284 cord tissue (Wharton's jelly) global developmental delay neurology 2016 experimental therapy Poland 6,9
285 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,8
286 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 39,6
287 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 13,2
288 cord tissue (Wharton's jelly) developmental delay neurology 2016 experimental therapy Poland 7,4
289 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 7,4
290 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 66
291 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Łódź 38,1
292 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8,4
293 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3
294 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 79,8
295 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 54,3
296 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 14,4
297 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 47,11
298 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,3
299 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,2
300 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 23,6
301 cord tissue (Wharton's jelly) age-related macular degeneration ophthalmology 2016 experimental therapy Poland 86,5
302 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 54,6
303 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Łódź 68,5
304 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 13,7
305 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,2
306 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 5,0
307 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12,11
308 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 12,3
309 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 1,3
310 cord tissue (Wharton's jelly) developmental delay neurology 2016 experimental therapy Poland 2,7
311 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 3,3
312 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 59,6
313 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 34,2
314 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 30,3
315 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 17,10
316 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 37,11
317 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 31,9
318 cord tissue (Wharton's jelly) ataxia hereditaria neurology 2016 experimental therapy Poland 69
319 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 31,9
320 cord tissue (Wharton's jelly) no data ophthalmology 2016 experimental therapy Poland 66,1
321 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,4
322 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 60,8
323 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,8
324 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 3
325 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 2,11
326 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 4,3
327 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland no data
328 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 59,4
329 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2016 experimental therapy Poland 20,11
330 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 53
331 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 24,5
332 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 34,7
333 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 32,3
334 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 65,9
335 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 52,7
336 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 71,5
337 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 60,7
338 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 1,10
339 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 7,6
340 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 1,10
341 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 29,7
342 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 68,5
343 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2016 experimental therapy Poland 8,12
344 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 44,5
345 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 9,2
346 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 24,5
347 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,7
348 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 15,9
349 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 6,8
350 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 10,3
351 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 16,4
352 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6
353 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 41,8
354 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 51,9
355 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,3
356 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 20,9
357 cord tissue (Wharton's jelly) fetal alcohol spectrum disorders neurology 2016 experimental therapy Poland 5,2
358 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 13,10
359 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 58,4
360 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 68,2
361 cord tissue (Wharton's jelly) chondronecrosis femoral condyle orthopedics 2016 experimental therapy Poland 54,11
362 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,4
363 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 41,2
364 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72,1
365 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,8
366 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 2,11
367 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 18
368 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4,1
369 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 48,1
370 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,3
371 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,10
372 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland no data
373 cord tissue (Wharton's jelly) gangliosidosis t. 1 neurology 2016 experimental therapy Poland 1,4
374 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14,9
375 cord tissue (Wharton's jelly) epileptic encephalopathy neurology 2016 experimental therapy Poland 3,6
376 cord tissue (Wharton's jelly) polineuropathy neurology 2016 experimental therapy Poland 70,8
377 cord tissue (Wharton's jelly) diffuse cartilage damage left medial compartment of the knee orthopedics 2016 experimental therapy Poland 50,5
378 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 37,7
379 cord tissue (Wharton's jelly) myopia,hyperopia,astigmatism,abnormal refraction and accommodation,optic atrophy ophthalmology 2016 experimental therapy Poland 37,1
380 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 33,5
381 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 16,2
382 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3,7
383 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 17,9
384 cord tissue (Wharton's jelly) injuries to the spinal nerves neurology 2016 experimental therapy Poland 5,12
385 cord tissue (Wharton's jelly) cartilage damage orthopedics 2016 experimental therapy Poland 57,6
386 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 4,8
387 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 44,7
388 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 10
389 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4,4
390 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 4,9
391 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2016 experimental therapy Poland 28,6
392 cord tissue (Wharton's jelly) neurodevelopmental disorders neurology 2016 experimental therapy Poland 4,5
393 cord tissue (Wharton's jelly) tetraparesis orthopedics 2016 experimental therapy Poland 27,2
394 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,2
395 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 44,8
396 cord tissue (Wharton's jelly) degeneration of the cartilage of the knee joint orthopedics 2016 experimental therapy Poland 54,3
397 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /BMD neurology 2016 experimental therapy Poland 19,2
398 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 15,0
399 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 31,11
400 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 33,4
401 cord tissue (Wharton's jelly) endometrial atrophy ginecology 2016 experimental therapy Poland 37,3
402 cord tissue (Wharton's jelly) endometrial atrophy ginecology 2016 experimental therapy Poland 39,1
403 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 38,4
404 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 44,5
405 cord tissue (Wharton's jelly) meniscus damage orthopedics 2016 experimental therapy Łódź 35,5
406 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,8
407 cord tissue (Wharton's jelly) premature ovarian failure ginecology 2016 experimental therapy Poland 23,4
408 cord tissue (Wharton's jelly) premature ovarian failure ginecology 2016 experimental therapy Poland 34,9
409 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,5
410 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 67,11
411 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 37,9
412 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 71,7
413 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Łódź no data
414 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 7,11
415 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 47,6
416 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2017 experimental therapy Poland 44,1
417 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 34,11
418 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 58,10
419 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 49
420 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 37,4
421 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 37,7
422 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 26,11
423 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 56,7
424 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 48,11
425 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 46,3
426 cord tissue (Wharton's jelly) cartilage damage orthopedics 2017 experimental therapy Poland 61,5
427 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 34,1
428 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Łódź 52,9
429 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2017 experimental therapy Poland 23,9
430 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 31,6
431 cord tissue (Wharton's jelly) age-related macular degeneration ophthalmology 2017 experimental therapy Poland 33,4
432 cord tissue (Wharton's jelly) tetraparesis spastica neurology 2017 experimental therapy Poland 29,4
433 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 24,9
434 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 10,6
435 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 30
436 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 56,8
437 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 65,2
438 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 45,9
439 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2017 experimental therapy Poland 28,6
440 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 44,2
441 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 41,4
442 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 25,8
443 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 75,9
444 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 23,7
445 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 43,4
446 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 39
447 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51,3
448 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 39
449 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 42,11
450 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 30,9
451 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 12,11
452 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 8,5
453 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2017 experimental therapy Poland 58,9
454 cord tissue (Wharton's jelly) cri du chat syndrome neurology 2017 experimental therapy Poland 8,6
455 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 18,7
456 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 59,8
457 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 22,1
458 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2017 experimental therapy Poland 28,11
459 cord tissue (Wharton's jelly) epilepsia neurology 2017 experimental therapy Poland 3,1
460 cord tissue (Wharton's jelly) cranium bifidum neurology 2017 experimental therapy Poland 5,2
461 cord tissue (Wharton's jelly) transverse myelitis neurology 2017 experimental therapy Poland 8,3
462 cord tissue (Wharton's jelly) syringomielia neurology 2017 experimental therapy Poland 42,6
463 peripheral blood acute myelogenous leukemia hematology January 2016 standard therapy United Kingdom 58
464 peripheral blood acute lymphoblastic leukemia hematology January 2016 standard therapy Poland 56
465 peripheral blood myelodysplastic syndrome hematology January 2016 standard therapy Austria 60
466 peripheral blood acute myelogenous leukemia hematology January 2016 standard therapy Australia 62
467 peripheral blood no data n/a January 2016 standard therapy Czech Republic 45
468 peripheral blood chronic lymphocytic leukemia hematology January 2016 standard therapy Slovakia 52
469 peripheral blood acute myelogenous leukemia hematology January 2016 standard therapy France 40
470 peripheral blood no data n/a January 2016 standard therapy Netherlands 70
471 peripheral blood no data n/a February 2016 standard therapy Poland 43
472 peripheral blood acute myelogenous leukemia hematology February 2016 standard therapy Poland 18
473 peripheral blood X-linked lymphoproliferative disease hematology February 2016 standard therapy Russia 12
474 peripheral blood chronic lymphocytic leukemia hematology February 2016 standard therapy Sweden 61
475 peripheral blood acute myelogenous leukemia hematology February 2016 standard therapy Germany 66
476 peripheral blood no data n/a February 2016 standard therapy Netherlands 69
477 peripheral blood acute lymphoblastic leukemia hematology February 2016 standard therapy Columbia 43
478 peripheral blood acute myelogenous leukemia hematology February 2016 standard therapy Germany 64
479 peripheral blood Hodgkin’s lymphoma hematology February 2016 standard therapy Poland 31
480 peripheral blood acute myelogenous leukemia hematology February 2016 standard therapy Czech Republic 54
481 peripheral blood T-cell leukemia/lymphoma hematology February 2016 standard therapy Canada 31
482 peripheral blood acute myelogenous leukemia hematology February 2016 standard therapy Poland 54
483 peripheral blood primary myelofibrosis hematology February 2016 standard therapy Germany 50
484 peripheral blood acute myelogenous leukemia hematology March 2016 standard therapy Poland 18
485 peripheral blood adrenoleukodystrophy metabolic March 2016 standard therapy Poland 1
486 peripheral blood acute myelogenous leukemia hematology March 2016 standard therapy Italy 31
487 peripheral blood no data n/a March 2016 standard therapy Poland 28
488 peripheral blood acute myelogenous leukemia hematology March 2016 standard therapy Sweden 35
489 peripheral blood no data n/a March 2016 standard therapy Czech Republic 1
490 peripheral blood Wiskott-Aldrich syndrome hematology March 2016 standard therapy Poland 1
491 peripheral blood no data n/a March 2016 standard therapy Belgium 30
492 peripheral blood no data n/a April 2016 standard therapy Germany 71
493 peripheral blood acute myelogenous leukemia hematology April 2016 standard therapy Germany 46
494 peripheral blood acute myelogenous leukemia hematology April 2016 standard therapy Germany 29
495 peripheral blood myelodysplastic syndrome hematology April 2016 standard therapy Czech Republic 56
496 peripheral blood acute myelogenous leukemia hematology April 2016 standard therapy France 32
497 peripheral blood acute myelogenous leukemia hematology April 2016 standard therapy Czech Republic 49
498 peripheral blood myelodysplastic syndrome hematology April 2016 standard therapy Germany 50
499 peripheral blood acute myelogenous leukemia hematology April 2016 standard therapy Poland 64
500 peripheral blood acute myelogenous leukemia hematology April 2016 standard therapy Poland 42
501 peripheral blood acute myelogenous leukemia hematology April 2016 standard therapy Germany 13
502 peripheral blood acute myelogenous leukemia hematology April 2016 standard therapy Slovakia 8
503 peripheral blood acute myelogenous leukemia hematology April 2016 standard therapy Belgium 46
504 peripheral blood refractory anemia with excess blasts hematology April 2016 standard therapy United Kingdom 62
505 peripheral blood acute myelogenous leukemia hematology May 2016 standard therapy Poland 40
506 peripheral blood myelodysplastic syndrome - RAEB hematology May 2016 standard therapy Poland 56
507 peripheral blood no data n/a May 2016 standard therapy Sweden 58
508 peripheral blood Hodgkin’s lymphoma hematology May 2016 standard therapy Germany 32
509 peripheral blood acute myelogenous leukemia hematology May 2016 standard therapy Germany 32
510 peripheral blood acute myelogenous leukemia hematology May 2016 standard therapy Germany 66
511 peripheral blood T Cell Lymphoma/ NOS - Not otherwise specified hematology May 2016 standard therapy Germany 55
512 peripheral blood acute myelogenous leukemia hematology May 2016 standard therapy Germany 43
513 peripheral blood no data n/a May 2016 standard therapy Czech Republic 59
514 peripheral blood aplastic anaemia hematology May 2016 standard therapy United Kingdom 23
515 peripheral blood myelodysplastic syndrome hematology May 2016 standard therapy Germany 73
516 peripheral blood myelofibrosis hematology May 2016 standard therapy Israel 72
517 peripheral blood acute lymphoblastic leukemia hematology May 2016 standard therapy Australia 61
518 peripheral blood primary myelofibrosis hematology May 2016 standard therapy Germany 67
519 peripheral blood myelodysplastic syndrome hematology May 2016 standard therapy Ireland 47
520 peripheral blood no data n/a May 2016 standard therapy Germany 17
521 peripheral blood no data n/a May 2016 standard therapy France 59
522 peripheral blood acute myelogenous leukemia hematology May 2016 standard therapy Germany 66
523 peripheral blood chronic lymphocytic leukemia hematology June 2016 standard therapy Germany 62
524 peripheral blood acute myelogenous leukemia hematology June 2016 standard therapy France 47
525 peripheral blood myelodysplastic syndrome hematology June 2016 standard therapy France 67
526 peripheral blood acute myelogenous leukemia hematology June 2016 standard therapy Lithuania 15
527 peripheral blood Hodgkin’s lymphoma hematology June 2016 standard therapy United Kingdom 18
528 peripheral blood acute myelogenous leukemia hematology June 2016 standard therapy Czech Republic 37
529 peripheral blood acute lymphoblastic leukemia hematology June 2016 standard therapy France 24
530 peripheral blood acute lymphoblastic leukemia hematology June 2016 standard therapy Canada 13
531 peripheral blood acute myelogenous leukemia hematology June 2016 standard therapy Hungary 57
532 peripheral blood acute myelogenous leukemia hematology June 2016 standard therapy Belgium 56
533 peripheral blood acute myelogenous leukemia hematology June 2016 standard therapy France 38
534 peripheral blood acute myelogenous leukemia hematology June 2016 standard therapy France 52
535 peripheral blood chronic myelomonocytic leukemia,minimal residual disease hematology July 2016 standard therapy Poland 50
536 peripheral blood myeloma multiplex hematology July 2016 standard therapy Germany 63
537 peripheral blood Fanconi anaemia hematology July 2016 standard therapy Estonia 7
538 peripheral blood plasma cell disorder hematology July 2016 standard therapy France 47
539 peripheral blood acute myelogenous leukemia hematology July 2016 standard therapy Germany 35
540 peripheral blood acute myelogenous leukemia hematology July 2016 standard therapy Germany 72
541 peripheral blood myeloma multiplex hematology July 2016 standard therapy Poland 51
542 peripheral blood acute lymphoblastic leukemia hematology July 2016 standard therapy Spain 58
543 peripheral blood myelodysplastic syndrome hematology July 2016 standard therapy Estonia 62
544 peripheral blood acute myelogenous leukemia hematology July 2016 standard therapy Hungary 46
545 peripheral blood acute lymphoblastic leukemia hematology July 2016 standard therapy Hungary 20
546 peripheral blood acute myelogenous leukemia hematology July 2016 standard therapy Italy 51
547 peripheral blood primary Immunodeficiency hematology July 2016 standard therapy Russia 5
548 peripheral blood acute myelogenous leukemia hematology July 2016 standard therapy United Kingdom 62
549 peripheral blood acute myelogenous leukemia hematology July 2016 standard therapy Germany 69
550 peripheral blood acute myelogenous leukemia hematology July 2016 standard therapy Australia 51
551 peripheral blood no data n/a July 2016 standard therapy Netherlands 58
552 peripheral blood acute myelogenous leukemia hematology July 2016 standard therapy Spain 38
553 peripheral blood acute lymphoblastic leukemia hematology July 2016 standard therapy Lithuania 23
554 peripheral blood chronic myeloid leukemia hematology July 2016 standard therapy Germany 62
555 peripheral blood Hodgkin’s lymphoma hematology July 2016 standard therapy Germany 32
556 peripheral blood acute lymphoblastic leukemia hematology August 2016 standard therapy Germany 27
557 peripheral blood acute lymphoblastic leukemia hematology August 2016 standard therapy Poland 30
558 peripheral blood acute myelogenous leukemia hematology August 2016 standard therapy Turkey 55
559 peripheral blood acute myelogenous leukemia hematology August 2016 standard therapy Israel 63
560 peripheral blood acute lymphoblastic leukemia hematology August 2016 standard therapy Turkey 37
561 peripheral blood acute myelogenous leukemia hematology August 2016 standard therapy Germany 66
562 peripheral blood acute lymphoblastic leukemia hematology August 2016 standard therapy Turkey 38
563 peripheral blood acute myelogenous leukemia hematology August 2016 standard therapy Germany 65
564 peripheral blood acute myelogenous leukemia hematology August 2016 standard therapy Poland 46
565 peripheral blood acute myelogenous leukemia hematology August 2016 standard therapy Germany 18
566 peripheral blood Hodgkin’s lymphoma hematology August 2016 standard therapy Netherlands 38
567 peripheral blood acute myelogenous leukemia hematology August 2016 standard therapy Turkey 48
568 peripheral blood myelodysplastic syndrome hematology August 2016 standard therapy Germany 61
569 peripheral blood acute myelogenous leukemia hematology August 2016 standard therapy France 67
570 peripheral blood no data n/a September 2016 standard therapy Poland 55
571 peripheral blood acute myelogenous leukemia hematology September 2016 standard therapy France 32
572 peripheral blood T-cell acute lymphoblastic leukemia hematology September 2016 standard therapy Germany 19
573 peripheral blood myelodysplastic syndrome hematology September 2016 standard therapy United Kingdom 68
574 peripheral blood acute myelogenous leukemia hematology September 2016 standard therapy Germany 59
575 peripheral blood myelodysplastic syndrome - RCMD hematology September 2016 standard therapy Czech Republic 32
576 peripheral blood myelodysplastic syndrome hematology September 2016 standard therapy Belgium 65
577 peripheral blood myelofibrosis hematology September 2016 standard therapy Netherlands 66
578 peripheral blood acute myelogenous leukemia hematology September 2016 standard therapy Switzerland 8,12
579 peripheral blood acute myelogenous leukemia hematology September 2016 standard therapy Israel 36
580 peripheral blood acute myelogenous leukemia hematology September 2016 standard therapy Germany 66
581 peripheral blood acute myelogenous leukemia hematology September 2016 standard therapy Denmark 68
582 peripheral blood myelodysplastic syndrome hematology September 2016 standard therapy Spain 15
583 peripheral blood myelodysplastic syndrome hematology September 2016 standard therapy Italy 52
584 peripheral blood chronic myelomonocytic leukaemia hematology September 2016 standard therapy Finland 53
585 peripheral blood no data n/a October 2016 standard therapy Turkey 4
586 peripheral blood leukemia hematology October 2016 standard therapy Lithuania 53
587 peripheral blood T-cell acute lymphoblastic leukemia hematology October 2016 standard therapy Serbia 21
588 peripheral blood myeloproliferative syndrome hematology October 2016 standard therapy Poland 52
589 peripheral blood acute myelogenous leukemia hematology October 2016 standard therapy France 63
590 peripheral blood no data n/a October 2016 standard therapy Poland 44
591 peripheral blood acute myelogenous leukemia hematology October 2016 standard therapy Czech Republic 60
592 peripheral blood T-cell acute lymphoblastic leukemia hematology October 2016 standard therapy Austria 41
593 peripheral blood primary myelofibrosis hematology October 2016 standard therapy Switzerland 67
594 peripheral blood myelodysplastic syndrome hematology October 2016 standard therapy United Kingdom 20
595 peripheral blood acute myelogenous leukemia hematology October 2016 standard therapy Brazil 37
596 peripheral blood myelodysplastic syndrome hematology October 2016 standard therapy France 60
597 peripheral blood acute myelogenous leukemia hematology October 2016 standard therapy Germany 61
598 peripheral blood acute myelogenous leukemia hematology October 2016 standard therapy Turkey 51
599 peripheral blood acute lymphoblastic leukemia hematology October 2016 standard therapy France 28
600 peripheral blood acute myelogenous leukemia hematology October 2016 standard therapy Poland 65
601 peripheral blood acute myelogenous leukemia hematology October 2016 standard therapy Italy 53
602 peripheral blood Lymphoblastic Lymphoma hematology October 2016 standard therapy Italy 33
603 peripheral blood acute lymphoblastic leukemia hematology October 2016 standard therapy Slovakia 30
604 peripheral blood myelodysplastic syndrome hematology October 2016 standard therapy Belgium 9
605 peripheral blood myeloma multiplex hematology October 2016 standard therapy Poland 38
606 peripheral blood acute lymphoblastic leukemia hematology October 2016 standard therapy Poland 39
607 peripheral blood myelodysplastic syndrome hematology November 2016 standard therapy Austria 61
608 peripheral blood acute myelogenous leukemia hematology November 2016 standard therapy New Zealand 59
609 peripheral blood acute myelogenous leukemia hematology November 2016 standard therapy Australia 62
610 peripheral blood acute myelogenous leukemia hematology November 2016 standard therapy Germany 65
611 peripheral blood acute myelogenous leukemia hematology November 2016 standard therapy Portugal 41
612 peripheral blood myelodysplastic syndrome hematology November 2016 standard therapy France 59
613 peripheral blood SAA / Amyloidosis hematology November 2016 standard therapy United Kingdom 45
614 peripheral blood chronic myeloid leukemia hematology November 2016 standard therapy Finland 46
615 peripheral blood acute myelogenous leukemia hematology November 2016 standard therapy Poland 50
616 peripheral blood acute lymphoblastic leukemia hematology November 2016 standard therapy Italy 66
617 peripheral blood non-Hodgkin lymphoma hematology November 2016 standard therapy Russia 38
618 peripheral blood acute lymphoblastic leukemia hematology November 2016 standard therapy Poland 20
619 peripheral blood myelofibrosis hematology November 2016 standard therapy France 67
620 peripheral blood B-cell Acute lymphoblastic leukemia hematology November 2016 standard therapy Belgium 44
621 peripheral blood non-Hodgkin lymphoma hematology November 2016 standard therapy Poland 58
622 peripheral blood acute myelogenous leukemia hematology November 2016 standard therapy Germany 72
623 peripheral blood acute myelogenous leukemia hematology November 2016 standard therapy United Kingdom 68
624 peripheral blood myelodysplastic syndrome hematology November 2016 standard therapy Germany 63
625 peripheral blood acute lymphoblastic leukemia hematology November 2016 standard therapy France 56
626 peripheral blood acute myelogenous leukemia hematology November 2016 standard therapy Poland 54
627 peripheral blood acute myelogenous leukemia hematology November 2016 standard therapy Poland 24
628 peripheral blood acute lymphoblastic leukemia hematology November 2016 standard therapy Greece 9
629 peripheral blood chronic myeloid leukemia hematology November 2016 standard therapy Germany 40
630 peripheral blood myelodysplastic syndrome hematology November 2016 standard therapy Germany 15
631 peripheral blood myelodysplastic syndrome hematology December 2016 standard therapy Germany 37
632 peripheral blood acute myelogenous leukemia hematology December 2016 standard therapy Russia 44
633 peripheral blood myelodysplastic syndrome hematology December 2016 standard therapy Germany 5 9
634 peripheral blood non-Hodgkin lymphoma hematology December 2016 standard therapy Russia 32
635 peripheral blood myelodysplastic syndrome hematology December 2016 standard therapy Germany 62
636 peripheral blood acute myelogenous leukemia hematology December 2016 standard therapy Poland 55
637 peripheral blood composite lymphoma hematology December 2016 standard therapy Germany 51
638 peripheral blood acute myelogenous leukemia hematology December 2016 standard therapy Italy 30
639 peripheral blood acute lymphoblastic leukemia hematology December 2016 standard therapy Germany 33
640 peripheral blood myelodysplastic syndrome hematology December 2016 standard therapy Italy 58
641 peripheral blood high-risk acute lymphoblastic leukemia hematology December 2016 standard therapy Poland 5
642 peripheral blood acute myelogenous leukemia M2/M4 hematology December 2016 standard therapy Germany 59
643 peripheral blood non-Hodgkin lymphoma hematology December 2016 standard therapy Netherlands 39
644 peripheral blood acute lymphoblastic leukemia hematology December 2016 standard therapy Italy 21
645 peripheral blood acute myelogenous leukemia hematology December 2016 standard therapy Spain 50
646 peripheral blood plasma cell disorder hematology December 2016 standard therapy France 54
647 peripheral blood acute myelogenous leukemia hematology December 2016 standard therapy United Kingdom 47
648 peripheral blood acute myelogenous leukemia hematology December 2016 standard therapy Canada 47
649 peripheral blood myelodysplastic syndrome hematology December 2016 standard therapy Germany 67
650 peripheral blood myelodysplastic syndrome hematology December 2016 standard therapy Germany 62
651 peripheral blood acute myelogenous leukemia hematology December 2016 standard therapy Italy 63
652 peripheral blood acute myelogenous leukemia hematology December 2016 standard therapy Poland 19
653 peripheral blood T-cell-prolymphocytic leukemia hematology December 2016 standard therapy United Kingdom 61
654 peripheral blood myelodysplastic syndrome hematology December 2016 standard therapy USA 69
655 peripheral blood acute lymphoblastic leukemia hematology December 2016 standard therapy France 35
656 peripheral blood severe aplastic anaemia hematology December 2016 standard therapy Russia 18
657 peripheral blood myelodysplastic syndrome hematology December 2016 standard therapy Germany 66
658 peripheral blood Hurler syndrome hematology January 2017 standard therapy United Kingdom 2
659 peripheral blood myeloma multiplex hematology January 2017 standard therapy Germany 44
660 peripheral blood myelodysplastic syndrome hematology January 2017 standard therapy Poland 60
661 peripheral blood acute lymphoblastic leukemia hematology January 2017 standard therapy USA 24
662 peripheral blood acute myelogenous leukemia hematology January 2017 standard therapy United Kingdom 51
663 peripheral blood chronic myeloproliferative neoplasm blast crisis hematology January 2017 standard therapy Germany 29
664 peripheral blood acute lymphoblastic leukemia hematology January 2017 standard therapy Poland 43
665 peripheral blood myelodysplastic syndrome hematology January 2017 standard therapy France 68
666 peripheral blood chronic myeloid leukemia hematology January 2017 standard therapy Turkey 29
667 peripheral blood severe aplastic anaemia hematology January 2017 standard therapy Poland 14
668 peripheral blood Niemann–Pick disease hematology January 2017 standard therapy Poland 2
669 peripheral blood acute lymphoblastic leukemia hematology January 2017 standard therapy Iran 17
670 peripheral blood myelodysplastic syndrome hematology January 2017 standard therapy Poland 3
671 peripheral blood non-Hodgkin lymphoma hematology January 2017 standard therapy USA 63
672 peripheral blood Common variable immunodeficiency,relapsed hemophagocytic syndrome hematology January 2017 standard therapy Germany 44
673 peripheral blood acute myelogenous leukemia hematology February 2017 standard therapy France 65
674 peripheral blood myelofibrosis hematology February 2017 standard therapy Spain 63
675 peripheral blood diffuse large B-cell lymphoma hematology February 2017 standard therapy Germany 61
676 peripheral blood myelodysplastic syndrome hematology February 2017 standard therapy USA 56
677 peripheral blood acute myelogenous leukemia hematology February 2017 standard therapy Italy 48
678 peripheral blood myelodysplastic syndrome hematology February 2017 standard therapy Austria 54
679 peripheral blood myelofibrosis hematology February 2017 standard therapy Denmark 63
680 bone marrow osteopetrosis metabolic January 2016 standard therapy Russia 6
681 bone marrow severe combined immunodeficiency hematology January 2016 standard therapy Romania 2
682 bone marrow T-cell acute lymphoblastic leukemia hematology February 2016 standard therapy Italy 4
683 bone marrow no data n/a March 2016 standard therapy Italy 3
684 bone marrow acute myelogenous leukemia hematology March 2016 standard therapy Italy 64
685 bone marrow acute lymphoblastic leukemia hematology March 2016 standard therapy Italy 9
686 bone marrow acute myelogenous leukemia hematology March 2016 standard therapy Spain 55
687 bone marrow Fanconi anaemia hematology March 2016 standard therapy Estonia 7
688 bone marrow acute lymphoblastic leukemia hematology April 2016 standard therapy Italy 6
689 bone marrow acute myelogenous leukemia hematology April 2016 standard therapy Italy 64
690 bone marrow acute lymphoblastic leukemia hematology April 2016 standard therapy Italy 14
691 bone marrow biphenotypic leukemia hematology May 2016 standard therapy Brazil 27
692 bone marrow acute lymphoblastic leukemia hematology May 2016 standard therapy Germany 7
693 bone marrow osteopetrosis metabolic May 2016 standard therapy Germany 1
694 bone marrow severe aplastic anaemia hematology June 2016 standard therapy France 9
695 bone marrow no data n/a June 2016 standard therapy Poland 7
696 bone marrow Hurler syndrome metabolic June 2016 standard therapy United Kingdom 2
697 bone marrow  severe combined immunodeficiency hematology July 2016 standard therapy Turkey 4
698 bone marrow acute lymphoblastic leukemia hematology July 2016 standard therapy Canada 11
699 bone marrow myelofibrosis hematology August 2016 standard therapy Germany 31
700 bone marrow DiGeorge syndrome hematology August 2016 standard therapy Netherlands 24
701 bone marrow Hodgkin’s lymphoma hematology August 2016 standard therapy Italy 17
702 bone marrow acute myelogenous leukemia hematology August 2016 standard therapy Belarus 12
703 bone marrow acute lymphoblastic leukemia hematology August 2016 standard therapy Belarus 18
704 bone marrow severe combined immunodeficiency hematology September 2016 standard therapy Poland 7,12
705 bone marrow severe aplastic anaemia hematology September 2016 standard therapy France 9
706 bone marrow severe aplastic anaemia / paroxymal nocturnal haemoglobinuria hematology September 2016 standard therapy Poland 17
707 bone marrow myelodysplastic syndrome hematology September 2016 standard therapy Hungary 1
708 bone marrow acute myelogenous leukemia hematology September 2016 standard therapy Italy 67
709 bone marrow myelodysplastic syndrome hematology September 2016 standard therapy Spain 56
710 bone marrow Fanconi anaemia hematology September 2016 standard therapy Netherlands 41
711 bone marrow acute lymphoblastic leukemia hematology October 2016 standard therapy France 5
712 bone marrow acute myelogenous leukemia hematology October 2016 standard therapy United Kingdom 29
713 bone marrow acute lymphoblastic leukemia hematology October 2016 standard therapy Belarus 25
714 bone marrow acute lymphoblastic leukemia hematology October 2016 standard therapy New Zealand 1
715 bone marrow severe combined immunodeficiency hematology October 2016 standard therapy Germany 12
716 bone marrow acute lymphoblastic leukemia hematology October 2016 standard therapy Poland 5
717 bone marrow no data n/a November 2016 standard therapy Poland 33
718 bone marrow non-Hodgkin lymphoma hematology November 2016 standard therapy Italy 46
719 bone marrow aplastic anaemia hematology November 2016 standard therapy Austria 20
720 bone marrow acute myelogenous leukemia hematology November 2016 standard therapy Croatia 33
721 bone marrow myeloproliferative syndrome hematology November 2016 standard therapy Poland 22
722 bone marrow acute myelogenous leukemia hematology December 2016 standard therapy Ireland 39
723 bone marrow Diamond-Balckfan anaemia hematology December 2016 standard therapy Germany 2
724 bone marrow acute myelogenous leukemia hematology December 2016 standard therapy Czech Republic 9
725 bone marrow acute lymphoblastic leukemia hematology December 2016 standard therapy Belarus 15
726 bone marrow juvenile myelomonocytic leukemia hematology December 2016 standard therapy Germany 3
727 bone marrow acute myelogenous leukemia hematology December 2016 standard therapy Finland 45
728 bone marrow anaemia hematology December 2016 standard therapy Germany 16
729 bone marrow acute lymphoblastic leukemia hematology December 2016 standard therapy Germany 6
730 bone marrow anaemia hematology December 2016 standard therapy Italy 5
731 bone marrow high-risk acute lymphoblastic leukemia hematology December 2016 standard therapy Poland 18
732 bone marrow acute lymphoblastic leukemia hematology January 2017 standard therapy Poland 6
733 bone marrow acute myelogenous leukemia hematology January 2017 standard therapy Germany 76
734 bone marrow acute myelogenous leukemia hematology January 2017 standard therapy Turkey 22
735 bone marrow chronic granulomatous disease hematology January 2017 standard therapy Poland 2
736 bone marrow acute myelogenous leukemia hematology January 2017 standard therapy Germany 65
737 bone marrow myelodysplastic syndrome hematology January 2017 standard therapy Italy 60
738 bone marrow myelodysplastic syndrome hematology January 2017 standard therapy USA 61
739 bone marrow acute lymphoblastic leukemia hematology February 2017 standard therapy Russia 30
{{$index+1}} {{item.source}} {{item.indication}} {{item.area}} {{item.year}} {{item.therapy}} {{item.country}} {{item.age | number}}

Last update: 22 February 2017